Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Detaylı Bibliyografya
Asıl Yazarlar:	Karavitaki, N, Wass, J
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2010

Benzer Materyaller

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
Yazar:: Karavitaki, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
Yazar:: Karavitaki, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
Yazar:: Emilia Sbardella, ve diğerleri
Baskı/Yayın Bilgisi: (2016-10-01)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Yazar:: Youngki Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
Yazar:: Shahzad Hira, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

The outcome of macroprolactinomas resistant to dopamine agonists
Yazar:: Coculescu, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
Yazar:: Ashu Rastogi, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
Yazar:: Bassam M Flamerz Arkawazi
Baskı/Yayın Bilgisi: (2020-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
Yazar:: Herring, N, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
Yazar:: Soni, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Yazar:: Lambert, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
Yazar:: Lambert, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
Yazar:: Souha S Elabd, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Cabergoline-induced mania in a patient of pituitary microadenoma
Yazar:: Satyakam Mohapatra, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
Yazar:: Ali S. Alzahrani, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Yazar:: Reddy, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
Yazar:: Michelle Maher, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Non-adenomatous pituitary tumours.
Yazar:: Karavitaki, N, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
Yazar:: Rogers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Nonfunctioning pituitary adenomas: the Oxford experience.
Yazar:: Wass, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
Yazar:: Arnold, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Yazar:: Arnold, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The postoperative monitoring of nonfunctioning pituitary adenomas.
Yazar:: Wass, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The postoperative monitoring of nonfunctioning pituitary adenomas
Yazar:: Wass, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Treatment of pituitary tumors: history.
Yazar:: Thanabalasingham, G, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR
Yazar:: sylvia andrea araneda, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
Yazar:: Pankaj Agrawal, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
Yazar:: Guadalupe Vargas-Ortega, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
Yazar:: Emre Bozkirli, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
Yazar:: Pratibha Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

The modern management of macroprolactinomas.
Yazar:: Grossman, A
Baskı/Yayın Bilgisi: (1991)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
Yazar:: DL Goede, ve diğerleri
Baskı/Yayın Bilgisi: (2006-04-01)

Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction
Yazar:: Tania Sundra, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
Yazar:: Suliman, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

No link to cardiac valvulopathy was seen in cabergoline treated patients
Yazar:: K Dharshini, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
Yazar:: Capatina, C, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
Yazar:: Barber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
Yazar:: Pankaj Agrawal, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
Yazar:: Fernandez, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Macroprolactinoma in an adolescent female with primary amenorrhoea
Yazar:: Ning Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)